Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion
Roche is set to expand its therapeutic portfolio with the acquisition of Poseida Therapeutics in a deal valued at up to $1.5 billion. This strategic move aims to enhance Roche's ca
